baber/WOPTO huggingface dataset:
Patent AU-2019271925-A1 (AU)
Title: Enhanced techniques for dewatering thick fine tailings
Inventor: REVINGTON ADRIAN
IPC: C10G1/04
Filed: 2019-11-26
Abstract: Techniques for dewatering thick fine tailings may include one or more pre-treatment steps, such as pre-shearing to reduce the yield stress prior to flocculation, hydrocarbon removal below a threshold to improve flocculation and dewatering, flocculant dosing on a clay basis, and providing certain properties of the thick fine tailings related to coarse and fine particle sizes and/or chemistry such as divalent cation content. Various advantages may result from pre-treatments based on thick fine tailings properties, such as reduced flocculant dosage requirements, improved dispersion of flocculant into the thick fine tailings and/or enhanced dewatering, for example. One or more of the pre-treatments may be performed.
Patent AU-2019301731-A1 (AU)
Title: Intake and exhaust valve system for an internal combustion engine
Inventor: LOONEY ALLEN EUGENE
IPC: F01L7/02
Filed: 2019-07-12
Abstract: In an internal combustion engine, first and second rotating members, one for the intake valve and one for the exhaust valve rotate next to the outside of an engine cylinder on opposite sides thereof when driven by a drive gear attached to the end of the engine's crankshaft. Each rotating member may include a ring gear having a valve port or aperture near its perimeter that cyclically aligns with a corresponding valve port formed through the cylinder wall near the top of the cylinder. A method of controlling valve timing comprises the steps of causing the rotating member containing the second valve port to periodically align in synchronism with the first port to control the passage of an air/fuel mixture and exhaust gases through the combustion cycles of the engine.
Patent AU-2019311290-A1 (AU)
Title: Therapeutic preparations of gamma-delta T cells and Natural Killer cells and methods for manufacture and use
Inventor: QUINTARELLI CONCETTA
IPC: C12N5/0783
Filed: 2019-07-25
Abstract: Provided are methods of making innate immune cell compositions containing gamma.delta (γδ) T cells and/or Natural Killer (NK) cells, and the resulting compositions and related products of manufacture and kits for use in cancer and infectious disease therapy. The methods provided herein permit tailoring of the relative amounts of gamma.delta (γδ) T cells and Natural Killer (NK) cells in the compositions, for cellular therapies against a wide variety of cancers and infectious diseases. The resulting compositions can further be used to generate compositions containing either NK cells alone or gamma.delta T cells alone, for immune cellular therapies. The compositions provided herein also can be genetically altered: the gamma delta T cells and Natural Killer cells are modified to express chimeric antigen receptors (CARs) or exogenous T cell receptors (TCRs), which can be used to target any cell surface molecule either directly or indirectly,
Patent AU-2019325457-A1 (AU)
Title: Rotary aeroponic apparatus and method
Inventor: MASSEY SCOTT
IPC: A01G31/06
Filed: 2019-08-20
Abstract: A plant growing apparatus that has at least one panel separating an interior from a surrounding environment and a plant housing assembly positioned at least partially in the interior, the plant housing assembly comprising at least one growth ring that defines at least one plant opening through a radial bend in a growth ring wall.
Patent AU-2019344410-A1 (AU)
Title: Method of treating wasting disorders
Inventor: ERIKSSON ULF
IPC: A61K39/395
Filed: 2019-09-18
Abstract: The present disclosure provides a method of treating a wasting disorder in a subject, the method comprising administering to the subject a compound that inhibits VEGF-B signalling. The present disclosure also provides a method of treating cancer cachexia in a subject suffering from cancer cachexia, the method comprising 5 administering to the subject a compound that inhibits VEGF-B signaling.
Patent AU-2019352901-A1 (AU)
Title: Measurement system
Inventor: KENDALL MARK ANTHONY FERNANCE
IPC: A61B5/296
Filed: 2019-10-01
Abstract: A system for performing measurements on a biological subject, the system including: at least one substrate including a plurality of plate microstructures configured to breach a stratum corneum of the subject; at least one sensor operatively connected to at least one microstructure, the at least one sensor being configured to measure response signals from the at least one microstructure; and, one or more electronic processing devices configured to: determine measured response signals; and, at least one of: provide an output based on measured response signals; perform an analysis at least in part using the measured response signals; and, store data at least partially indicative of the measured response signals.
Patent AU-2019358211-A1 (AU)
Title: Shaped stator windings for a switched reluctance machine and method of making the same
Inventor: DESAI PIYUSH
IPC: H02K3/04
Filed: 2019-10-14
Abstract: The present invention is a method for producing a plurality of curved stator windings by shaping a plurality of stator coils for a switched reluctance machine (SRM). The present invention proposes apparatus and methods for utilizing a plurality of curved stator windings with two main embodiments: a symmetrical winding and an asymmetrical winding, whereby the plurality of curved stator windings are highly conforming to a curved stator shape. The plurality of curved stator windings provides higher efficiency and lower noise to the SRM. The plurality of curved stator windings conforms to the stator curved shape, maximizing the copper fill factor, thereby permitting maximum copper utilization in the machine.
Patent AU-2019361964-A1 (AU)
Title: Degraders of wild-type and mutant forms of LRKK2
Inventor: GRAY NATHANAEL S
IPC: A61K47/54
Filed: 2019-10-16
Abstract: Disclosed are bifunctional compounds (degraders) that target LRKK2 for degradation. Also disclosed are pharmaceutical compositions containing the degraders and methods of using the degraders to treat neurodegenerative diseases and disorders such as Parkinson's disease and brain cancer (
Patent AU-2019364352-A1 (AU)
Title: 5-membered heteroaryl carboxamide compounds for treatment of HBV
Inventor: HAYDAR SIMON NICOLAS
IPC: C07D417/10
Filed: 2019-10-22
Abstract: The present disclosure provides, in part, 5-membered heteroaryl carboxamide compounds, and pharmaceutical compositions thereof, useful for disruption of HBV core protein assembly, and methods of treating Hepatitis B (HBV) infection.
Patent AU-2019370989-A1 (AU)
Title: TCR and peptides
Inventor: BONINI MARIA CHIARA
IPC: C07K14/725
Filed: 2019-10-31
Abstract: A T-cell receptor (TCR), which binds to a Wilms tumour 1 protein (WT1) peptide when presented by a major histocompatibility complex (MHC).
Patent AU-2019376641-A1 (AU)
Title: Mini-nucleosome core proteins and use in nucleic acid delivery
Inventor: KOIRALA ADARSHA
IPC: C12N15/62
Filed: 2019-11-06
Abstract: The present disclosure provides compositions and methods relating to mini-nucleosome core proteins and/or delivery of nucleic acids. In particular, the present disclosure includes, among other things, non-viral proteinaceous vehicles for delivery of nucleic acids. In various embodiments, non-viral proteinaceous vehicles provided herein include (a) a nucleic acid binding domain; (b) a targeting domain; and, optionally, (c) a nucleic acid release domain, stability domain, and/or an oligomerization domain, and/or a linker domain.
Patent AU-2019387627-A1 (AU)
Title: System and method for automated post-geosteering
Inventor: THORNE JULIAN A
IPC: E21B47/024
Filed: 2019-11-04
Abstract: A method is described for automated post-geosteering including receiving a pilot well log and a lateral well log with an initial lateral well path (10); performing automated post-geosteering to generate a corrected well path image; and displaying the corrected well path image (14) on a graphical display. The method may be executed by a computer system.
Patent AU-2019389139-A1 (AU)
Title: Electrostatic spray drying nozzle assembly
Inventor: ACKERMAN THOMAS
IPC: B05B7/08
Filed: 2019-11-27
Abstract: An electrostatic sprayer (10, 70) operable at high flow rates and low pressures particularly suitable for spray drying. The sprayer (10, 70) includes an elongated body (12) having a downstream spray nozzle assembly (14, 71) through which electrically charged liquid is directed via a central feed tube (18) within the nozzle body (12) and atomizing air is supplied via an annular passage (25) about the liquid feed tube (18). In one embodiment, the nozzle assembly is an external mix cluster head spray nozzle assembly (14) having a plurality of circumferentially spaced metallic spray tips (40). In another embodiment, the spray nozzle is an internal mix nozzle assembly *71) having a spray tip (71) with an internal mixing chamber (72a) for atomizing liquid prior to discharge.
Patent AU-2019393669-A1 (AU)
Title: Lock assembly
Inventor: ZHAO JIANPING
IPC: E05B63/14
Filed: 2019-11-28
Abstract: A lock assembly, comprising: a drive hub configured to be rotated in a first angular direction; a latch having a latch engaged position; a lock having a locked position; a first locking member configured such that, when the lock is in the locked position, the first locking member retains the latch in the latch engaged position; and a second locking member configured such that, when the lock is in the locked position, the second locking member prevents the drive hub from rotating in the first angular direction.
Patent AU-2019404588-A1 (AU)
Title: Implantable medical device with adjustable blood flow
Inventor: VECCHIO CHRISTOPHER J
IPC: A61B5/0215
Filed: 2019-12-23
Abstract: An implantable medical device is disclosed, in which the implantable medical device includes a fluid shunt extending through a wall separating a first cavity and a second cavity within the heart. The fluid shunt includes a first portion adapted to extend into the first cavity within the heart, a second portion adapted to extend into the second cavity within the heart, and an intermediate portion interconnecting the first and second portions. The fluid shunt having a lumen extending between the first and second portions that is adapted to fluidly couple the first and second cavities within the heart. The implantable medical device also includes an occlusion assembly associated with the fluid shunt and adapted to selectively occlude flow through the lumen of the fluid shunt, where the occlusion assembly is activated to adjust flow through the lumen of the fluid shunt, The implantable medical device further includes at least one sensor assembly associated with the first portion of the fluid shunt such that the at least one sensor assembly senses one or more physiologic parameters in the first cavity.
Patent AU-2019454689-A1 (AU)
Title: Distance based session roaming
Inventor: WEI DAOWEN
IPC: H04L12/20
Filed: 2019-06-28
Abstract: Typically, when a user switches sessions between devices, the user authenticates the sessions by providing user account information, password, and/or pin code input or other credentials. However, when the user is frequently switching sessions between devices, authenticating sessions may result in the user reducing or even stopping switching across mobile devices. Systems and methods according to this disclosure provide automatic session roaming across mobile devices using proximity authentication. Upon detecting an indication to initiate session roaming, the source device automatically roams the session on the source device to a target device based on a proximity of the source device to the target device. The session is handed off from the source device to the target device as an authenticated user session.
Patent AU-2019480667-A1 (AU)
Title: An adjuvant composition and the agricultural composition comprising the same
Inventor: MONTEROSSO RENATO
IPC: A01P3/00
Filed: 2019-12-23
Abstract: The present application relates to an adjuvant concentrate composition comprising a liquid medium, a drift reduction agent, a non-ionic surfactant and water. The present application further comprise an agricultural concentration composition comprising the same and the preparation method thereof.
Patent AU-2020203600-A1 (AU)
Title: Intelligent inert measurement mode
Inventor: JENSEN JESPER
IPC: G08B21/16
Filed: 2020-06-01
Abstract: A method for gas detection comprising: receiving, by a gas detector, sensed data indicative of oxygen content in the ambient air, the gas detector having a first alarm setting comprising a first predefined threshold; when the sensed data is below the first predefined threshold, activating, by the gas detector, an alarm; determining when the gas detector enters an inert work zone; and when the gas detector has entered the inert work zone, deactivating the alarm and altering one or more settings of the gas detector, wherein altering the one or more settings of the gas detector comprises changing the first predefined threshold to a second predefined threshold, and the gas detector is configured to activate the alarm when the sensed data is above the second predefined threshold. WO 2018/101928 PCT/US2016/064162 120 --\,z- 12 2 NORMAL OPERATION ZONE I IINERT ZONEI 10--II GAS DETECTORII 106t- PROCESSORII 1:12- USER INTERFACE I r L NORMAL OPERATION ZONE INRIZN j--102 I I GAS DETECTOR 02 IIOSENSOR410 I ROCESSOR 0 US IER INTERFACES -1
Patent AU-2020203732-A1 (AU)
Title: Telescopic protective assembly for jumper cable
Inventor: HE SAILONG
IPC: H01B7/00
Filed: 2020-06-05
Abstract: A telescopic protective assembly for jumper cable comprises at least a telescopic protective 
subassembly (10). The telescopic protective subassembly (10) comprises two protective sleeves 
with different sizes comprising a large-sized protective sleeve (1) and a small-sized protective 
sleeve (2), and an adapter (3) which is formed with a central hole. The adapter (3) comprises a first 
end (31) where the central hole has a large diameter and a second end (32) where the central hole 
has a small diameter. The large-sized protective sleeve (1) is connected with the first end (31) of 
the adapter (3), and the small-sized protective sleeve (2) is connected with the second end (32).  
The small-sized protective sleeve (2) can be moved relative to the second end (32).  
(Fig 1.)
1/5 
C141 
C>O 
coz 
U--
Patent AU-2020204419-A1 (AU)
Title: Compositions and methods for modulating neuronal excitability and motor behavior
Inventor: SCHAEFER ANNE
IPC: A61K48/00
Filed: 2020-07-01
Abstract: COMPOSITIONS AND METHODS FOR MODULATING NEURONAL EXCITABILITY 
AND MOTOR BEHAVIOR 
The invention is directed to compositions and methods for treating or reducing 
the likelihood of the development of epilepsy in an individual. The method comprises 
administering to the central nervous system of an individual in need of such treatment 
a therapeutically effective amount of an agent capable of increasing the expression 
and/or activity of miR-128.  
12407738_1 (GHMatters) P103102.AU.1
Patent AU-2020213309-A1 (AU)
Title: Fading reduced beverage
Inventor: IZUMI AKIKO
IPC: A23L2/58
Filed: 2020-08-05
Abstract: The present invention has an object to provide a beverage wherein fading of a 
caramel coloring is reduced. The present invention also has an object to provide a method 
for producing such a beverage and a method for reducing the caramel coloring fading in the 
beverage.  
The beverage meeting the following conditions (A) and (B): (A) a ratio of a content 
of RebD or RebM to a content of RebA is 0.45 or more, and (B) a caramel coloring is 
contained so that Lab values of the beverage are respectively L: 45 to 55, a: 10 to 20, and b: 
25 to 35.
Patent AU-2020214032-A1 (AU)
Title: Benzopyridone heterocyclic compound and use thereof
Inventor: FANG HUAXIANG
IPC: C07D401/04
Filed: 2020-01-19
Abstract: A compound represented by formula I, or a pharmaceutically acceptable salt thereof, or a stereoisomer thereof, or a tautomer thereof, or a hydrate thereof, or a solvate thereof, or a metabolite thereof, or a prodrug thereof. R1-R5 and group A are as defined in the description. The compound is used for the preparation of drugs for treating diseases caused by KRAS G12C mutation and for treating and/or preventing cancers.
Patent AU-2020217708-A1 (AU)
Title: Adeno-associated virus delivery of CLN3 polynucleotide
Inventor: MEYER KATHRIN
IPC: C12N15/86
Filed: 2020-02-04
Abstract: The present disclosure relates to recombinant adeno-associated virus (rAAV) delivery of a ceroid lipofuscinosis neuronal 3 (CLN3) polynucleotide. The disclosure provides rAAV and methods of using the rAAV for CLN3 gene therapy of the neuronal ceroid lipofuscinosis or CLN3 -Batten Disease.
Patent AU-2020223505-A1 (AU)
Title: CT contrast agent for detection of cachexia
Inventor: BABIC ANDREJ
IPC: A61K49/04
Filed: 2020-02-13
Abstract: The invention relates to an iodinated CT contrast agent for non-invasive diagnosis of cachexia. This is possible by superior resolution of CT combined with CT contrast agent specific for the brown and/or beige adipose tissue (BAT).
Patent AU-2020228671-A1 (AU)
Title: Vent system for patient interface
Inventor: HOGG MICHAEL
IPC: A61M16/20
Filed: 2020-02-26
Abstract: A vent structure may include a vent housing comprising an inlet, an outlet, at least one exhaust gas orifice, and a membrane having a first end and a second end spaced apart, the membrane having a moveable portion between the first end and the second end. The moveable portion may be spaced radially from a membrane-facing surface inside of the vent housing to form an exhaust gas flow passage therebetween to allow exhaust gas to flow from the pressurised volume through the exhaust gas flow passage to atmosphere via the exhaust gas orifice. The moveable portion may be elastically deformable and configured to move radially relative to the membrane-facing surface in response to pressure differences between an interior side of the membrane and an exterior side of the membrane to change a cross-sectional area of the exhaust gas flow passage and regulate the vent flow of gas.
Patent AU-2020233287-A1 (AU)
Title: Devices, systems, and methods for delivering therapeutic agents into a stomach wall
Inventor: IMRAN MIR
IPC: A61K9/48
Filed: 2020-02-28
Abstract: Embodiments of the invention provide swallowable devices, preparations and methods for delivering drugs and other therapeutic agents (TA) within the GI tract and in particular to an antrum wall (AW). Particular embodiments provide a swallowable device (SD) such as a capsule for delivering drugs or other TA into the AW. The SD may contain a pressure sensitive component or assembly which triggers release and insertion of a therapeutic agent preparation (TAP) comprising at least one TA into the AW in response to external pressure, such as pressure applied to the swallowable capsule or other SD by antrum contractions. Particular embodiments of the SD may be shaped so that they self-align within an antrum to properly orient before injection of the TAP into the AW. Embodiments of the invention are particularly useful for orally delivering drugs or other TAs which are degraded within the GI tract and require parenteral injection.
Patent AU-2020233437-A1 (AU)
Title: Carbonated beverage
Inventor: MATSUBAYASHI HIDEKI
IPC: A23L2/00
Filed: 2020-03-02
Abstract: The purpose of the present invention is to provide a carbonated beverage in which the sense of carbonation is enhanced.　This carbonated beverage contains 0.10-2.0 mg/100 mL of 1-deoxynojirimycin.
Patent AU-2020239225-A1 (AU)
Title: Novel high fidelity RNA-programmable endonuclease systems and uses thereof
Inventor: SCHMIDT MORITZ
IPC: A61K38/00
Filed: 2020-03-12
Abstract: Described herein are novel systems for targeting, editing or manipulating DNA in a cell, using novel M- SmallCas9 nucleases and variants thereof. The M-SmallCas9 nucleases are derived from wildtype or parental small type II CRISPR Cas9 endonucleases, and display improved fidelity compared to parental type II CRISPR Cas9 enzymes in combination with a simple PAM sequences and are small endonuclease size.
Patent AU-2020241896-A1 (AU)
Title: Claudin-6 antibodies and drug conjugates
Inventor: CONKLIN DYLAN
IPC: A61K39/395
Filed: 2020-03-20
Abstract: The present disclosure provides antigen-binding proteins which bind to Claudin-6 (CLDN6). In various aspects, the antigen-binding proteins bind to Extracellular Loop 2 (EL2) of the extracellular domain of CLDN6. Related polypeptides, nucleic acids, vectors, host cells, and conjugates are further provided herein. Kits and pharmaceutical compositions comprising such entities are moreover provided. Also provided are methods of making an antigen-binding protein and methods of treating a subject having cancer.
Patent AU-2020260673-A1 (AU)
Title: Motor-driven medical suction pump and method for connecting such a suction pump to a power source
Inventor: HONEGGER ADRIAN
IPC: H01R13/22
Filed: 2020-03-12
Abstract: The present invention relates to a motor-driven suction pump and a method for connecting such a pump. The suction pump has a pump unit for generating a negative pressure which is accommodated in a housing (2). Further, a terminal box (10) is provided which can be connected to a power source via a connecting cable (30) and has contact elements (16, 18) for supplying the pump unit with a power current. The contact elements (16, 18) are electrically conductively connected to the contact counter elements (46, 48) provided on the housing side and leading to the pump unit when the terminal box (10) is coupled to the housing (2). In order to increase electrical safety, a sensor (22), an evaluation unit (32), and a switch (34) are provided. The sensor (22) is configured to check the coupling of the terminal box (10). The switch (34) switches a power supply to at least one of the contact elements (16, 18). The evaluation unit (32) is data-based connected to the sensor (22) and the switch (34) such that the switch connects the contact element (16, 18) to the power current supply when a signal of the sensor (22) confirming the coupling is present and disconnects the power current supply when a signal of the sensor (22) confirming the coupling is absent. In the method according to the invention, at least one contact element (16, 18) which is switched off is first electrically connected to the counter contact element (46, 48) on the housing side, which is provided for supplying current to the pump unit. The power current is then applied to the contact element (16, 18) on the basis of a signal confirming the corresponding contacting.
Patent AU-2020271280-A1 (AU)
Title: Method for continuously producing an active ingredient granulate
Inventor: NOWAK REINHARD
IPC: A61K9/16
Filed: 2020-04-09
Abstract: The invention relates to a method for continuously producing an active ingredient granulate, having the following steps: (a) producing a spray composition in which an active ingredient and optionally one or more auxiliary agents are dissolved or dispersed in a liquid; (b) providing solid particles in a processing chamber; (c) introducing drops made of the spray composition into an injection zone of the processing chamber in which the liquid is evaporated; (d) repeatedly guiding the solid particles past injected drops in the processing chamber using a processing gas jet such that at least a proportion of the drops which could have already lost some of the contained liquid is brought into contact with solid particles, and larger solid particles are formed by attachment; and (e) removing the active ingredient granulate from the processing chamber in the form of solid particles, wherein the active ingredient has a Hausner ratio of 1.19 or more when used.